Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Migraine with aura following atrial septostomy for pulmonary arterial hypertension

Abstract

Background A 34-year-old woman with known familial pulmonary arterial hypertension presented with syncope. Despite medical therapy with an endothelin-receptor antagonist and a phosphodiesterase inhibitor, the patient had NYHA class III symptoms, with exertional dyspnea. Right heart catheterization revealed severe pulmonary hypertension (right atrial pressure 15 mmHg, right ventricular pressure 80/15 mmHg, pulmonary artery pressure 80/35 mmHg, mean pulmonary artery pressure 52 mmHg). The patient underwent balloon atrial septostomy, creating a right-to-left shunt. Although she had no history of headaches or migraine attacks, the patient developed a migraine headache with aura on the third day after the procedure. Migraine attacks recurred for the next 2 days, but symptoms were relieved with simple analgesia.

Investigations Physical examination, electrocardiography, laboratory testing, 6-min-walk test, right heart catheterization, chest radiography, transesophageal echocardiography, transthoracic echocardiography.

Diagnosis Migraine with aura following atrial septostomy.

Management Bosentan, sildenafil, furosemide, spironolactone and warfarin therapy, atrial septostomy, and paracetamol therapy for migraine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Headache classification committee of the HIS (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalagia 8: 1–96

  2. Gaine SP and Rubin LJ (1998) Primary pulmonary hypertension. Lancet 352: 719–725

    Article  CAS  Google Scholar 

  3. Hopkins WE et al. (1996) Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 15: 100–105

    CAS  PubMed  Google Scholar 

  4. Rozkovec A et al. (1986) Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 55: 449–558

    Article  CAS  Google Scholar 

  5. Rich S and Lam W (1983) Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol 51: 1560–1561

    Article  CAS  Google Scholar 

  6. Sandoval J et al. (1998) Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 32: 297–304

    Article  CAS  Google Scholar 

  7. Kerstein D et al. (1995) Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 91: 2028–2035

    Article  CAS  Google Scholar 

  8. Azarbal B et al. (2005) Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45: 489–492

    Article  Google Scholar 

  9. Schwerzmann M et al. (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62: 1399–1401

    Article  CAS  Google Scholar 

  10. Droste DW et al. (1998) Low frequency of clinically silent circulating emboli in patients with mitral valve prolapse or patent foramen ovale detected by bigated transcranial Doppler ultrasound. Neurol Res 20: 499–503

    Article  CAS  Google Scholar 

  11. Wilmshurst PT et al. (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356: 1648–1651

    Article  CAS  Google Scholar 

  12. Wilmshurst PT et al. (2005) Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 91: 1173–1175

    Article  CAS  Google Scholar 

  13. Giardini A et al. (2006) Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 151: 922.e1–5

    Article  Google Scholar 

  14. Mortelmans K et al. (2005) The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 26: 1533–1537

    Article  Google Scholar 

  15. Wertman B et al. (2006) Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol 47: 1226–1227

    Article  Google Scholar 

  16. Sitbon O et al. (2005) Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111: 3105–3111

    Article  CAS  Google Scholar 

  17. Rubin LJ ; American College of Chest Physicians (2004) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (Suppl): S7–S10

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sean P Gaine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogan, M., Walsh, K. & Gaine, S. Migraine with aura following atrial septostomy for pulmonary arterial hypertension. Nat Rev Cardiol 4, 55–58 (2007). https://doi.org/10.1038/ncpcardio0746

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0746

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing